These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36235540)

  • 1. Hyaluronan Oligosaccharides-Coated Paclitaxel-Casein Nanoparticles with Enhanced Stability and Antitumor Activity.
    Wang M; Zhang Y; Fei Z; Xie D; Zhang H; Du Q; Jin P
    Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin E-Oligo(methyl diglycol l-glutamate) as a Biocompatible and Functional Surfactant for Facile Preparation of Active Tumor-Targeting PLGA Nanoparticles.
    Wu J; Zhang J; Deng C; Meng F; Zhong Z
    Biomacromolecules; 2016 Jul; 17(7):2367-74. PubMed ID: 27305935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronic acid decorated pluronic P85 solid lipid nanoparticles as a potential carrier to overcome multidrug resistance in cervical and breast cancer.
    Wang F; Li L; Liu B; Chen Z; Li C
    Biomed Pharmacother; 2017 Feb; 86():595-604. PubMed ID: 28027535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paclitaxel-loaded redox-sensitive nanoparticles based on hyaluronic acid-vitamin E succinate conjugates for improved lung cancer treatment.
    Song Y; Cai H; Yin T; Huo M; Ma P; Zhou J; Lai W
    Int J Nanomedicine; 2018; 13():1585-1600. PubMed ID: 29588586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High paclitaxel-loaded and tumor cell-targeting hyaluronan-coated nanoemulsions.
    Kim JE; Park YJ
    Colloids Surf B Biointerfaces; 2017 Feb; 150():362-372. PubMed ID: 27823852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronic acid-modified selenium nanoparticles for enhancing the therapeutic efficacy of paclitaxel in lung cancer therapy.
    Zou J; Su S; Chen Z; Liang F; Zeng Y; Cen W; Zhang X; Xia Y; Huang D
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3456-3464. PubMed ID: 31469318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronic acid coated poly(butyl cyanoacrylate) nanoparticles as anticancer drug carriers.
    He M; Zhao Z; Yin L; Tang C; Yin C
    Int J Pharm; 2009 May; 373(1-2):165-73. PubMed ID: 19429302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of HA oligosaccharide-loaded nanoparticles to breach the endogenous hyaluronan glycocalyx for breast cancer therapy.
    Yang C; Liu Y; He Y; Du Y; Wang W; Shi X; Gao F
    Biomaterials; 2013 Sep; 34(28):6829-38. PubMed ID: 23764114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifunctional tumor-targeting nanocarriers based on hyaluronic acid-mediated and pH-sensitive properties for efficient delivery of docetaxel.
    Song S; Chen F; Qi H; Li F; Xin T; Xu J; Ye T; Sheng N; Yang X; Pan W
    Pharm Res; 2014 Apr; 31(4):1032-45. PubMed ID: 24154802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor microenvironment targeting with dual stimuli-responsive nanoparticles based on small heat shock proteins for antitumor drug delivery.
    Shi K; Wang Y; Zhou X; Gui H; Xu N; Wu S; He C; Zhao Z
    Acta Biomater; 2020 Sep; 114():369-383. PubMed ID: 32688090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifunctional Hyaluronic Acid-Decorated Redox-Responsive Magnetic Complex Micelle for Targeted Drug Delivery with Enhanced Antitumor Efficiency and Anti-Cell-Migration Activity.
    Sang M; Zhang Z; Liu F; Hu L; Li L; Chen L; Feng F; Liu W; Qu W
    J Biomed Nanotechnol; 2018 Mar; 14(3):477-495. PubMed ID: 29663921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of a chemopreventive agent and paclitaxel in CD44-targeted hybrid nanoparticles for breast cancer treatment.
    Tran BN; Nguyen HT; Kim JO; Yong CS; Nguyen CN
    Arch Pharm Res; 2017 Dec; 40(12):1420-1432. PubMed ID: 29027133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD44 Receptor Targeting and Endosomal pH-Sensitive Dual Functional Hyaluronic Acid Micelles for Intracellular Paclitaxel Delivery.
    Liu Y; Zhou C; Wang W; Yang J; Wang H; Hong W; Huang Y
    Mol Pharm; 2016 Dec; 13(12):4209-4221. PubMed ID: 27796093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-delivery of cisplatin and doxorubicin by covalently conjugating with polyamidoamine dendrimer for enhanced synergistic cancer therapy.
    Guo XL; Kang XX; Wang YQ; Zhang XJ; Li CJ; Liu Y; Du LB
    Acta Biomater; 2019 Jan; 84():367-377. PubMed ID: 30528609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irinotecan and 5-fluorouracil-co-loaded, hyaluronic acid-modified layer-by-layer nanoparticles for targeted gastric carcinoma therapy.
    Gao Z; Li Z; Yan J; Wang P
    Drug Des Devel Ther; 2017; 11():2595-2604. PubMed ID: 28919710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycyrrhetinic acid-graft-hyaluronic acid conjugate as a carrier for synergistic targeted delivery of antitumor drugs.
    Zhang L; Yao J; Zhou J; Wang T; Zhang Q
    Int J Pharm; 2013 Jan; 441(1-2):654-64. PubMed ID: 23117024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian cancer targeted hyaluronic acid-based nanoparticle system for paclitaxel delivery to overcome drug resistance.
    Wang L; Jia E
    Drug Deliv; 2016 Jun; 23(5):1810-7. PubMed ID: 26530693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronan oligomers-HPMA copolymer conjugates for targeting paclitaxel to CD44-overexpressing ovarian carcinoma.
    Journo-Gershfeld G; Kapp D; Shamay Y; Kopeček J; David A
    Pharm Res; 2012 Apr; 29(4):1121-33. PubMed ID: 22350800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural Modification of Nanomicelles through Phosphatidylcholine: The Enhanced Drug-Loading Capacity and Anticancer Activity of Celecoxib-Casein Nanoparticles for the Intravenous Delivery of Celecoxib.
    Xv L; Qian X; Wang Y; Yu C; Qin D; Zhang Y; Jin P; Du Q
    Nanomaterials (Basel); 2020 Mar; 10(3):. PubMed ID: 32131561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming drug-resistant lung cancer by paclitaxel-loaded hyaluronic acid-coated liposomes targeted to mitochondria.
    Tian Y; Zhang H; Qin Y; Li D; Liu Y; Wang H; Gan L
    Drug Dev Ind Pharm; 2018 Dec; 44(12):2071-2082. PubMed ID: 30112929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.